<DOC>
	<DOCNO>NCT01270308</DOCNO>
	<brief_summary>The objective study compare relative bioavailability Lansoprazole DR Capsules 30 mg Prevacid® Capsules 30 mg fast condition healthy adult human subject .</brief_summary>
	<brief_title>Bioequivalence Study Lansoprazole DR Capsules 30 mg Fasting Conditions</brief_title>
	<detailed_description>open label , randomize , two-treatment , three-period , three-sequence , partial replicate oral bioequivalence study Lansoprazole 30 mg DR Capsules Dr.Reddy 's Laboratories Limited , India compare PREVACID® ( contain Lansoprazole ) 30 mg DR Capsules TAP Pharmaceuticals Inc. USA , healthy , adult , human subject fast condition . 48 healthy , adult , human subject enrol study 42 subject complete study .</detailed_description>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<criteria>. Provided write informed consent . ii . Subject healthy , adult , human being within 18 45 year age ( inclusive ) weigh least 50 kg . iii . Subject body mass index 18.0 29.9 ( inclusive ) , calculate weight Kg/height m2 . iv . Subject normal health determine medical history , physical examination laboratory investigation perform within 28 day prior commencement study . ( Laboratory value must within normal limit consider physician /investigator clinical significance ) . v. Female Subjects child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . postmenopausal least 1 year . surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject ) . Subject incapable understanding informed consent . ii . Systolic blood pressure le 90 mm Hg 140 mm Hg . iii . Diastolic blood pressure le 60 mm Hg 90 mm Hg . iv . Oral temperature 95.0°F 98.6°F . v. Pulse rate 50/min 100/min . vi . History hypersensitivity idiosyncratic reaction investigational drug product relate drug . vii . Any evidence impairment renal , hepatic , cardiac , lung gastrointestinal function . viii . Consumption grapefruit past ten day prior checkin , period . ix . Regular smoker habit smoke nine cigarette per day difficulty abstain smoke sample collection period . x . Habit alcoholism difficulty abstain alcohol sample collection period . xi . Difficulty abstain xanthene contain food beverage ( like tea , coffee , chocolates cola drink ) sample collection period . xii . Intake counter ( OTC ) prescribe medication enzyme modify medication systemic medication last 30 day dose . xiii . Clinically significant abnormality / significant disease . xiv . Confirmed positive alcohol screening . xv . Confirmed positive select drug abuse . xvi . Subjects participate clinical investigation use experimental drug/donated blood past 90 day date start study xvii . Confirmed positive urine pregnancy test . xviii . Female detect pregnant , breast feeding likely become pregnant study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>two way crossover</keyword>
</DOC>